EGFR and lung cancer: In addition, the role of blood sample by liquid biopsy has to be mentioned when considering the acquired drug-resistance, such as the detection of epidermal growth factor receptor (EGFR) mutations in lung cancer (113); moreover, it is believed that molecular resistance is seen earlier than clinical resistance, and early finding of molecular resistance is also conductive to early-intervention.